Latest data from September 24, 2021
Number of Health Center respondents = 11 (92% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 10,052 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 33.52% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 1,325 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 34.09% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 62.93% | 61.43% |
| White, Hispanic/Latino Patients | 7.35% | 7.09% |
| Black/African American, Non-Hispanic/Latino Patients | 18.70% | 17.21% |
| Black/African American, Hispanic/Latino Patients | 0.09% | 0.23% |
| Asian Patients3 | 0.50% | 0.53% |
| American Indian/Alaska Native Patients3 | 0.33% | 0.45% |
| Native Hawaiian/Other Pacific Islander Patients3 | 1.11% | 0.91% |
| Patients with More than one race3 | 0.89% | 1.51% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 2.77% | 3.85% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 0.73% | 0.68% |
| Unreported/Refused to Report Race and Ethnicity | 4.61% | 6.11% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,024 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 62.39% |
| COVID-19 Immunization Series Completed | 1,453 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 56.17% |
| COVID-19 Immunization Series Additional | 23 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 9.09% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 34.96% | 40.12% | 86.96% |
| White, Hispanic/Latino Patients | 11.91% | 9.57% | 4.35% |
| Black/African American, Non-Hispanic/Latino Patients | 25.59% | 30.08% | 4.35% |
| Black/African American, Hispanic/Latino Patients | 0.59% | 0.07% | 0.00% |
| Asian Patients3 | 1.07% | 0.62% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.59% | 0.55% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 6.15% | 1.24% | 0.00% |
| Patients with More than one race3 | 2.83% | 3.37% | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 9.28% | 5.92% | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.56% | 1.24% | 0.00% |
| Unreported/Refused to Report Race and Ethnicity | 5.47% | 7.23% | 4.35% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 9.09% |
| 1 to 24 Hours | 18.18% |
| More Than 24 Hours | 72.73% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 0.00% |
| Staffing to administer the vaccine | 27.27% |
| Vaccine confidence | 45.45% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 9.09% |
| None | 36.36% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 111.82% |
| Average Percent of Health Center Visits Conducted Virtually | 11.82% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 54.55% |
| Number of Mobile Van Sites | 14 |
| Number of Pop-up Clinics | 9 |
| Number of School-Based Vaccination Sites | 6 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 45.45% |
| Refer patients to another organization that provides monoclonal antibody therapies | 36.36% |
| None | 27.27% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 0.00% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 0.00% |
| Therapy administration/onsite logistics | 9.09% |
| Other | 18.18% |
| None | 72.73% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
